![](/img/cover-not-exists.png)
Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity
Chlebowski, R. T., Haque, R., Hedlin, H., Col, N., Paskett, E., Manson, J. E., Kubo, J. T., Johnson, K. C., Wactawski-Wende, J., Pan, K., Anderson, G.Volume:
154
Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-015-3647-1
Date:
December, 2015
File:
PDF, 387 KB
english, 2015